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To obtain information on the regulution of glucose transport across the bosolater;tl membrane (BLM) of intestinal upithelinl cells, WC measured 
the number of~H]cytochalasin I3 binding sites and the level of liver-type glucose tmnsportcr (GLUT2) protein in the BLM in the jejunum of rats 
(i) with diabetes {ii) given a high-carbohydrate diet or (iii) with cxperimcntal hyperglycemia (12 h infusion of a high-glucose solution). A glucose 
uptake and the number orb-glucose inhibitublu [3H]cytochnlasin B binding sites in DLM vesicles were significantly increased in all three conditions. 
Western blot analysis showed that the amount of GLUT2 protein in BLM vesicles was increased in rats with dinbctcs and those given a 
high-carbohydrate diet, but not in ~hosc with experimental hyperglycemia. These results suggest hat there is a mechanism for rapid regulation 
of glucose transport in the BLM thnt does not depend on change in the amount of GLUT2. 
D-Glucose transport; Basolateral membrane; GLUT’; Diubetcs; High-glucose infusion: Rat intestine 
1. INTRODUCTION 
Glucose is transported across the small intestine by 
a two step process; the first step is entry of glucose into 
the cpithelium across the brush border membrane 
(BBM), and the second is its efflux from cells across the 
basolateral membrane (BLM) into the blood [l]. The 
molecular mechanism of glucose transport across the 
BBM via the Na”-dependent glucose co-transporter 
(SGLTI) has been well characterized by Wright. et al. 
[2], but little is known about glucose transport across 
the BLM. 
Recently, cDNAs for 5 facilitative glucose trans- 
porters (GLUTI-5) have been isolated [3]. GLUT2 has 
been shown to be present in the liver, small intestine, 
kidney and the islets of Langerhans [4,5]. Thorens et al. 
suggested that, as GLUT2 has a relative high K,, for 
glucose, it may be required for glucose sensing by/3-cells 
in islets. This glucose transporter is also present in the 
BLM of intestinal epithelial cells, and is responsible for 
the release of glucose across the BLM [4-63. Gould et 
al. found that the K, value for glucose of GLUT2 ex- 
pressed in Xerlopus oocytes is consistent with that re- 
ported by others for BLM preparations from rat smell 
intestine [7]. 
Previously we showed that the SGLTI, GLUT2 and 
GLUTS genes are expressed in rat jejunum, and that in 
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the jejunum of acute diabetic rats the level of GLUT2 
mRNA changed in parallel with the D-glucose transport 
activity, whereas the level of SGLTl, which is located 
in the BBM, did not change [8]. These results suggest 
that the induction of glucose transport occurs in the 
BLM of intestinal epithelial cells, not in the BBM. 
Recently facilitative glucose transport across the 
ELM was found to be induced by experimental hyper- 
glycemia (infusion of high-glucose solution) or a high- 
glucose diet [lo-131. However, nothing is yet known 
about the regulation of the GLUT2 protein in the BLM 
of intestinal epithelial cells. Therefore, in the present 
study, we investigated the levels of GLUT2 protein in 
rats with diabetes, those given high-carbohydrate diet 
and those with experimental hyperglycemia (12 11 infu- 
sion of high-glucose solution). Our results clearly indi- 
cate differential mechanisms for the regulation of baso- 
lateral glucose transport in rat small intestine. 
2. MATERIALS AND METHODS 
2.1. E.xperilrtertral didxres 
Male Sprague-Duwley rats (Japan SLC, Shizuoka, Japan), weigh- 
ing lGO-180 g, were used. The animals were housed in stainless-steel 
cuges and given a carbohydrate-free diet (24% protein. 55% fat, 9% 
cellulose, 4% mineral mixture and 1% vitamins), for 2 weeks before 
experiments, because the level of dietary sugar significantly affects the 
level ofliver-type glucose transporter (GLUT2) mRNAin ratjejunum 
[9], Most diet components were purchased from Wnko Chemical In- 
dustries (Osaka, Japan). The animals hnd free access to water and were 
mitinlilimxi m&r it i2-B ii&~t:ciiWk CjdC at 24°C. Anirna!s ivcre made 
diabetic by intraperitoneal injection of 65 mg/kg streptozocin (STZ) 
freshly dissolved in 100 mM citrate buffer (pi-i 4.5). Control rats 
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received asimilar injection of citrate buffer only. Animals were given 
a cnrbohydrate-free diet and were killed 10 days after STZ injection, 
as described previously [S]. 
Intravenous infusion experiments were carried out as described by 
Mocnz and Cheeseman [lO,l2]. Rats (160-180 g) maintained on a 
carbohydrate-l&z diet for 2 weeks were anesthetized with pcntobarbi- 
tal and a t&c was inserted into the jugular vein and pushed into the 
heart. The other end of the tube was brought out through an incision 
in the back. On the day of use, animals were placed in a small cage 
and connected to an infusion tube, and a solution of 50% glucose wns 
infused at 6.0 ml/h. After infusion for 12 h, the animals were killed and 
the jejunum WBS used for preparation of the BLM. 
2.3. if&h-cutbohydru~c d&r 
Animals (I SO-170 g) were maintained for 2 weeks on R carbohy- 
drate-f’rc- diet and then given a 55% glucose diet (55% gluco5c in place 
of 55% fat) for 5 days before experiments 1141. 
2.4. Preporatio,z of BLMJrunl iutcrtirtal cpirldiul cdh 
Rats wcrc anesthetized by intraperitoneal injection of pntobarbi- 
tal. the abdomen was opened and the porlal vein was cut. Then warm 
(37OC) I50 mM phosphate-buffered 0.9% saline. conruining 30 mM 
EDTA; pH 7.4, wns injected into the left ventricle, and the small 
intestine 1x15 removed and inverted over a glass rod. Cells :vcre re- 
leased by shaking, suspended in cold sucrose burer, and collected by 
low-sped ccntrifugation [IS]. BLM vesicles were prepared by diffcr- 
cntial centrifugalion and final purification on a Percoll gradient, as 
describrti by Scalera et al. [IO]. The final BLM pellet showed a 16.fold 
increase in spccitic activity of Na’,K+-ATPase over that of tbc crude 
preparation. There was no significant difference in tbc Na*,K+-ATP- 
nse activities in BLM preparations from rnts with hyperglycemia and 
diabetes and those fed a high-carbohydmte diet. 
2.5. Glucose uprake cm1 cytociralnsh 6 billing assoy in the BLM 
Olucosc transport and binding orcytochalasin B to the BLM from 
rat jejunum were measured by the methods of Maenr and Cheeseman 
[Ill. Membranes were incubated for I5 min with the ligand in the 
presence of 2 ,uM cytochalasin E to reduc% non-specific binding. The 
membranes were pelleted by ccntrifuzation for 30 min and the supr- 
natant was removed before dissolving the pellet in sodium hydroxide. 
For assay of the glucose-inhroiublc ytochalasin I3 binding, incuba- 
tions were performed with cit!ler 1.25 M o-glucose or 1.25 M sorbital 
in the medium. The amount ofcytochalasin B bound to BLM vesicles 
was calculated after correction for unbound [‘M]cytochalasin nssoci- 
ated with the pellet using [“‘Cluren as a non-binding aqueous pace 
marker. Binding constants were calculated using a computer program. 
In experiments on glucose uptake, 10 ,ul of vesicles (10 mg protein/ 
ml) was incubated with 20~1 of uptake medium for 3 sand the reaction 
was stopped with I.455 ~1 of ice-cold buffer containing 0.2 mM phlo- 
retin. The mixture was promptly Altered through a 0.45 pm pore size 
filter, which was then washed twice with 5 ml oT stop solution [11,12]. 
2.7. wL?slrrll l!lIolrirl.g 
GLUT2 untibody was kindly provided by B. Thorens [17]. This 
antibody was further purified as the IgG fraction by DE-52 cellulose 
column chromatography. Membranes were rcsuspcnded in Laemmli 
sample buffer containing 5% SDS and separated on a 10% SDS- 
polyacrylamidc gel 1181. Elcctrotrnnsfer to nitrorrllulose filters was 
performed for 6 h. The Rlters were washed at room temperature for 
10 min in TBST (20 mM Tris. III-I 7.4. 150 mhl N&I. and 0.02% 
Twccn 2ii). The fiitcrs were blocked with 0.5% fat-free dry milk, and 
incubated with anti-pcptidc antibodies (IgG fraction) against rat 
GLUTZ. They were thep wnshcd with TBST at room temperature, and 
incubated with iii’ cpm oi p lz5f-:abc:cd protcir, =JmI TBST, C:nrll . ..,,..y 
they were washed for 60 min in TEST and exposed to Kodak XAR 
Alms at -7OOC. Quanlificadon was performed by scanning densitom- 
etry. 
2.8. hfurrrials 
t@H]glucose, [‘H]cytochalnsin B, [“‘Clurca and [‘351]protcin A were 
purchased from Amersham. Cytochalnsin B. cytochalasin E, I@.I- 
case and D-sorbitol were from Sigma Chemical Co. 
3. RESULTS 
Membranes isolated from rat jejunum were analyzed 
for a marker enzyme of the BLM. Their specific activity 
of Na*,K*-ATPase was about 16-fold that of the crude 
extract (crude homogenate, 9.4 1: 1.8 humol FQ/hlmg 
protein; BLM, 150.9 $ 19.6 pmol POJhlmg protein). 
GLUT2 antiserum reacted with a band of 61 kDa pro- 
A 
Fig. 1. Western blot analyses of GLUT2 and sucrase in the brush- 
border (BBM) and basoluterai membrane (BLM) of rat jcjunum. (A) 
Sucrasc, (B) GLUT2. Intestinal BBM were prepared by the method 
of Macnr and Cheeseman [IO]. The membrane from r;ltsmall intestine 
was purified in the presence of the protease inhibitors, aprotinin, 
phcnylmethylsulfonyl fluoride, N-p-tosyllysine chloromcthyl ketone, 
f?-tosyl-L-phsnyhlaninechloromethyl ketoneand Futhan [5.26]. After 
scpnration by SDS-PAGE, the proteins were tmnsferred el=tro- 
phoretically to a nitrocellulosc filter by the method of Towbin et al. 
122. The filter was incubated with anti-GLUT2 and anti-sucrase anti- 
body for 2 h, and then incubated with proxidas+coupled gOat anti- 
rabbit IgG [5,28]. The bound antibody was located by staining with 
4-chloro naphthoi. 
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Fig. 2. Scatchard plots of D-glucose-inhibitable [“I-l]cytochnlasin E3 
binding to purified jejunnl BLM prepared from rats with hypurglyce- 
mia, and dinbctcs and those fed a high-carbohydrate. D-Glucose-in- 
hibitnble [“H]cytochalasin B binding was determined as described in 
section 2. The data are taken from two typical expcrimcnts in which 
membranes from 8 rats were pooled, and points represent meana for 
triplicate determinations. (A) Diabetes, (B) hyperglycemia, (C) high- 
carbohydrate. (0) Control group. (a) !cst group. 
tcin in the BLM from ral intestinal epithelial cells, but 
not with any protein in the brush-border or microsomal 
membranes (Fig. 1). This observation that the molecu- 
lar weight of intestinal GLUT2 is 61 kDa is consistent 
with a report of Thorens et al. [17]. 
Western blotting for sucrase as a marker enzyme of 
br> mh_ho&r . ..I.. " rrmrnt)ram=c $_Rr?rJ) rmwal~rl +l~t dhe . ..w... .1.._" ._*w...__ 
preparations were not contaminated with BBM. 
Fig. 2 shows the data for [‘H]cytochalasin B binding 
to BLM prepared from rats with diabetes (A) and exper- 
imental hyperglycemia (B), and those given a high-car- 
bohydrate diet (C). The number of binding sites were 
clearly increased in all three groups, and these increases 
paralleled changes in the I’,,, for transport [lo-131. The 
I’ mun values for n=glucose-inhibitable cytochalasin B 
binding in the groups with diabetes and hyperglycemia 
and those given a high-carbohydrate diet were 30.2 $ 
5.1 pmol/mg protein (n = 6), 29.5 f 4.6 pmol/mg protein 
(n = 6) and 36.5 f 6.6 pmohmg protein (11 = 7), the 
control values being 15.7 f 3.2 pmollmg protein, 14.3 
2 4.8 pmollmg protein and 19.1 f 3.2 pmol/mg protein, 
respectively. The binding affinities of these groups were 
the same: diabetes, 124.7 & 12.9 @I (control, 119.8 z!~ 
2 1.8 PM); hyperglycemia, 119.5 1: 21.8 ,uM (control, 
110.6 f 11.7); high-carbohydrate diet, 121.3 f 20.8 ,uM 
(control, 120.6 z!z 17.5 PM). The uptakes of 50 mM 
glucose in these animals are shown in Fig. 3. ~-Glucose 
transport across the BLM vesicle was significantly in- 
creased in all test groups relative to that of the control. 
This was largely a consequence of an increased V,,,, not 
a reduced KI [IO-i 31. An increase in [‘H]cytochalasin i3 
binding was consistent with the induction of transport 
observed in ELM preparations. 
Previously we found that the level of GLUT2 mRNA 
changed in parallel with D-galactose transport activity 
in the jejunum of diabetic rats [S]. As shown in Fig. 4A, 
the amount of GLUT2 protein increased about 3.0-fold 
in the BLM vesicles obtained from diabetic rats 10 days 
after STZ injection. The blood glucose level increased 
to a maximum 3 days after STZ injection [S]. As shown 
in Fig. 4C, a high-glucose diet increased in the intestinal 
level of GLUT2 protein about 2.6-fold after 5 days. The 
observation that GLUT2 protein increased in rats fed 
a high-carbohydrate diet is consistent with the results 
-- 
Df sbetc& hcrglyccmia Bigh-eark&dratc 
Fig. 3. Glucose uptake across BLM vesicles prcpdred from rats wilh 
hyperglycemiu and diirbetes and those fed a high-carbohydrate diet. 
The uptake of glucose into vesicles was initiated by mining 10 yl of 
vesicles with 20 ~1 of uptake mdia containing b-glucose I- a-[‘H]glu- 
case [I 1,121. Uptuke was initiated by vortcxing the tube and. at the 
conclusion of the uptake period, 1,455 ~1 of ice-cold stop solution was 
rapidly injected into the mixture. Glucose held by the vesicles was 
determined as dcscribcd in section 2. A correction for passive pcrme- 
ittic:: was mndc by subtracting the uptake of the same concentrations 
of L-glucose. The bars indicate the SD. from the mean (II = 6). (A) 
Diabetes, (II) hyperglycemia, (C) high-carbohydrate. (0) Control 
group, (m) lc51 group. 
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Fig. 4. Western blot of GLUT2 protein in BLM vesicles from rats with 
hyperglycemia, nd diabetes and those fed high-carbohydrate diet. 
Purified membranes (SO~goTmembrane protein/lane) were subjected 
to SDS-108 PAGE and trnnskrred to nylon filters. The filters were 
then incubated with anti-peptidc antibody of rat GLUT2 ;Ind Izsl- 
labeled protein A and subjected to autoradiography. (A) Diabetes. (B) 
hyperglycemia. (C) high-carbohydrate diet. Lane C, control group; 
lanes l-6, test group. 
obtained in the cytocalasin B binding experiments [!3]. 
Glucose infusion resulted in significant hyperglycemia 
(12-h infusion of glucose. plasma gluccse = 296 f 30 
mg/ml; saline infusion, 160 & 19 mdml). The effect of 
a 12-h intravenous infusion of glucose on the level of 
intestinal GLUT2 protein is shown in Fig. 4B. The 
GLUT2 protein level was not increased by the 12-h 
infusion of glucose compared with that of saline infu- 
sion, although [31-l]cytochalasin l3 binding increased sig- 
nificantly in these rats (Fig. 2B). We examined whether 
GLUT2 was present in other membrane fractions in 
hyperg@emic rats jqjunum but detected no im- 
munoreactive band of the protein in brush-border or 
microsomal p:.embrane preparations. Therefore, we 
concluded that the GLUT2 protein level did not in- 
crease over the control level in rats with hyperglycemia. 
4. DISCUSSION 
Numerous studies have shown that the transport ca- 
pacity of the small intestine is altered by a variety of 
conditions such as change in dietary conditions, lacta- 
tion, resection, and disease [lo-!3,19-221. Many of 
these adaptational responses take several days and are 
after? exp!aiEed by alterations in intestinal morphology 
[l]. However, there are reports that the response of 
glucose transport to hyperglycemia is a much more 
rapid type [I 3,211. In the present study, we also ob- 
served a rapid response of intestinal glucose transport 
in rats with experimental hyperglycemia (12 h-infusion 
of high-glucose solution). In these rats, unlike in those 
with diabetes and those on a high carbohydrate diet, 
increase in the number of [3M]cytochalasin B binding 
sites in the BLM was not associated by increase in the 
amount of intestinal GLUT2 protein. This difference 
was not due to differences in the extents of contamina- 
tion of the BLM preparations, because there were no 
significant differences in the specific activities of marker 
enzymes for the BLM in preparations from the three 
groups (data not shown). 
Other glucose transporter isoforms might be associ- 
ated with the glucose transport activity in the BLM in 
rats with hyperglycemia, because the cytochalasin B 
binding assay measured the total number of trans- 
porters irrespective of their isoform [23]. Cheeseman et 
al. observed rapid regulation of the glucose transporter 
in BLM vesicles by [3H]cytochalasin B binding assay 
ilo- 31. lnfiision of high-giucosc solution for 6 h stimu- 
lated glucose transport @-fold) and increased cytocha- 
lasin B binding to 1 .8-fold that of non-infused animals. 
However, vesicles prepared from animals 4 h after in 
vivo injection of cycloheximide showed 80% reduction 
in glucose transport with no significant change in the 
cytochalasin B binding [12]. The increase in transport 
resulting from hyperglycemia ppears to be due to in- 
crease in the functional activity of existing carriers in the 
membrane followed by recruitment of new carriers, as 
in fat cells [24]. They suggest hat newly recruited carri- 
ers could have a lower K, and a higher turnover rate. 
We performed RNA-blot analyses of rat small intcs- 
tine with GLUT!, -3, -4 and -5 cDNA, but could detect 
no signal except that for GLUT5 mRNA [8,9]. Re- 
cently, Davidson et al. showed thal GLUT5 protein is 
located in the BBM in human small intestine [25]. We 
could not detect this transporter in the BLM in rat 
jejunum with rabbit anti-GLUT5 antibody (RaGLUT- 
SAP, East Acres, Biogenesis, Bourncmoulh, UK). Since 
the affinity for glucose transport and cytochalasin B 
binding in the BLM of :* with hyperglycemia is simi- 
lar to those in ratr .I diabetes and those given a 
high-carbohydrate i ,, we suggest hat the functional 
glucose transporter in Lhe BLM of rals with hyperglyce- 
mia may have a low affinity for glucose, like that of 
GLUTZ. 
As the changes in transport capacity in the small 
intestinal BLM are not nearly as marked as those in 
adipocytes, they may correspond to a physical response 
occurring shortly after the start of a meal that increases 
the absorption of a very important nutrient [!2]. The 
interesting finding in the present study was that there 
was a mechanism for rapid regulation of glucose trans- 
port that does not depend on change in the amount of 
GLUT2. 
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